All In Biotech

Drug Trial Radar · NCT00003634

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

A Double-Blind Placebo Controlled Trial of Intravenous OvaRex MAb-B43.13 as Post Chemotherapy Consolidation for Ovarian Tubal and Peritoneal Carcinoma

Last checked: Nov 19, 2026Latest source record: Nov 6, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

400

Planned (sponsor's estimate)

Start

Apr 1998

Primary completion

Not stated

Sponsor

Lead sponsor
AltaRexIndustry
Sponsor type
Industry
First posted
Sep 13, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether giving monoclonal antibody therapy is more effective than a placebo in treating patients with ovarian epithelial, fallopian tube, or peritoneal cancer who have responded to surgery and chemotherapy. PURPOSE: Randomized phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients with residual disease from stage III or stage IV ovarian epithelial, fallopian tube, or peritoneal cancer following surgery and chemotherapy.

Conditions

  • Fallopian Tube Cancer
  • Ovarian Cancer
  • Primary Peritoneal Cavity Cancer

Interventions

  • oregovomabBiological

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

46 sites in 2 countries. Site status is shown where the registry gives one.

  • Alta Bates Comprehensive Cancer Center

    Berkeley, California

  • USC/Norris Comprehensive Cancer Center

    Los Angeles, California

  • Jonsson Comprehensive Cancer Center, UCLA

    Los Angeles, California

  • Chao Family Comprehensive Cancer Center

    Orange, California

  • Wilshire Oncology Medical Center

    Pomona, California

  • Stanford University School of Medicine

    Stanford, California

  • University of Colorado Cancer Center

    Denver, Colorado

  • Patty Berg Cancer Center

    Fort Myers, Florida

  • University of Florida Health Science Center - Jacksonville

    Jacksonville, Florida

  • Walt Disney Memorial Cancer Institute

    Orlando, Florida

  • University of Chicago Cancer Research Center

    Chicago, Illinois

  • Saint Mary's Hospital

    East Saint Louis, Illinois

  • Lutheran General Cancer Care Center

    Park Ridge, Illinois

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Alton Ochsner Medical Foundation Hospital

    New Orleans, Louisiana

  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland

    Baltimore, Maryland

  • New England Medical Center Hospital

    Boston, Massachusetts

  • Henry Ford Hospital

    Detroit, Michigan

  • University of Minnesota Medical School

    Minneapolis, Minnesota

  • Ellis Fischel Cancer Center

    Columbia, Missouri

  • North Shore University Hospital

    Manhasset, New York

  • State University of New York - Upstate Medical University

    Syracuse, New York

  • University of Oklahoma

    Oklahoma City, Oklahoma

  • Spartanburg Regional Medical Center

    Spartanburg, South Carolina

  • Baptist Regional Cancer Center - Knoxville

    Knoxville, Tennessee

  • University of Texas Southwestern Medical School

    Dallas, Texas

  • U.S. Oncology

    Houston, Texas

  • Cancer Center, University of Virginia HSC

    Charlottesville, Virginia

  • Swedish Hospital Tumor Institute

    Seattle, Washington

  • Tom Baker Cancer Center - Calgary

    Calgary, Alberta, Canada

  • Cross Cancer Institute

    Edmonton, Alberta, Canada

  • British Columbia Cancer Agency - Fraser Valley Cancer Centre

    Surrey, British Columbia, Canada

  • British Columbia Cancer Agency

    Vancouver, British Columbia, Canada

  • Manitoba Cancer Treatment and Research Foundation

    Winnipeg, Manitoba, Canada

  • Saint John Regional Hospital

    Saint John, New Brunswick, Canada

  • Nova Scotia Cancer Centre

    Halifax, Nova Scotia, Canada

  • Northeastern Ontario Regional Cancer Centre, Sudbury

    Greater Sudbury, Ontario, Canada

  • Cancer Care Ontario-Hamilton Regional Cancer Centre

    Hamilton, Ontario, Canada

  • Cancer Care Ontario-London Regional Cancer Centre

    London, Ontario, Canada

  • Credit Valley Hospital

    Mississauga, Ontario, Canada

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.